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Aims: Acute pancreatitis (AP) is an inﬂammatory condition wherein pro-inﬂammatory mediators, oxidative
stress, and NF-κB signaling play a key role. Currently, no speciﬁc therapy exists and treatment is mainly sup-
portive and targeted to prevent local pancreatic injury and systemic inﬂammatory complications. This study
was aimed to examine whether 1,8-cineole, a plant monoterpene with antioxidant and anti-inﬂammatory
properties could ameliorate cerulein-induced acute pancreatitis.
Main methods: AP was induced in Swiss mice by six one hourly injections of cerulein (50 μg/kg, i.p.). 1,8-cineole
(100, 200 and 400 mg/kg, p.o.) was administered 1 h prior to ﬁrst cerulein injection, keeping vehicle and thalido-
mide treated groups as controls. Blood samples were taken 6-h later to determine serum levels of amylase and
lipase, and cytokines. The pancreas was removed for morphological examination, myeloperoxidase (MPO) and
malondialdehyde (MDA) assays, reduced glutathione (GSH) levels, and for nuclear factor (NF)-κB immunostaining.
Key ﬁndings: 1,8-cineole effectively reduced the cerulein-induced histological damage, pancreatic edema and
NF-κB expression, levels of MPO activity and MDA, and replenished the GSH depletion. Cerulein increased
serum levels of amylase and lipase, and pro-inﬂammatory cytokines TNF-α, IL-1β, and IL-6were also decreased
by 1,8-cineole pretreatment, similar to thalidomide, a TNF-α inhibitor. The anti-inﬂammatory IL-10 cytokine
level was, however, enhanced by 1,8-cineole.
Signiﬁcance: These ﬁndings indicate that 1,8-cineole can attenuate cerulein-induced AP via an anti-inﬂammatory
mechanism and by combating oxidative stress. Further studies are needed to clearly elucidate its beneﬁts in
patients on acute pancreatitis.© 2013 Elsevier Inc. All rights reserved.Introduction
Acute pancreatitis (AP) is a morbid inﬂammatory condition of
pancreas with no speciﬁc treatment available. The incidence of pan-
creatitis has increased in general population during the past two decades
(Frossard et al., 2008), much of which may be due to cholelithiasis,
alcohol abuse, hypertriglyceridaemia, hyperparathyroidism, pancreatic
malignancy, obesity, endoscopic retrograde cholangiopancreatography
(ERCP), trauma, infectious agents, drugs, autoimmunity, and hereditary
(Frossard et al., 2008; Zamri and Razman, 2012). The pathogenesis
of pancreatitis remains still obscure and multifactorial. The disease isand Pharmacology, Faculty of
Melo, 1127, Rodolfo Teóﬁlo,
41; fax: +55 85 33668333.
rights reserved.believed to initiate in acinar cells with the intra-acinar cell activation
of pancreatic proenzymes and NF-κB (Huang et al., 2013) leading to
local and systemic overwhelming production of inﬂammatory mediators
and early organ dysfunction (Kylänpää et al., 2012) with death of acinar
cells throughboth necrosis and apoptosis. Participation of reactive oxygen
species and a role for oxidative stress play an important role in the path-
ogenesis of AP in animalmodels and in humans and a signiﬁcantly greater
serum concentrations of sulfhydryl groups and thiobarbituric acid reac-
tive substances (TBARS) were observed in the early phase of human AP
(Dziurkowska-Marek et al., 2004; Leung and Chan, 2009). Agents that
prevent oxidative stress, inﬂammation, and acinar cell injury during the
early phase of acute pancreatitis may arrest the pathologic progression
to severe pancreatitis that leads to signiﬁcant morbidity and mortality.
Current therapies included theuse of antisecretory agents, protease inhib-
itors, antioxidants, immunomodulators, non-steroidal anti-inﬂammatory
medications, and prophylactic antibiotics (Easler et al., 2012). A few of
1196 P.R. Lima et al. / Life Sciences 92 (2013) 1195–1201these therapies have demonstrated promise in signiﬁcantly altering the
progression of this disease and the search for more effective therapy
continues.
1,8-cineole (eucalyptol), is a major monoterpenoid present in many
plant volatile/essential oils, principally the Rosemarinus and Eucalyptus
species (Elaissi et al., 2012; Tschiggerl and Bucar, 2010). It is often
employed by the pharmaceutical industry in drug formulations, as a
percutaneous penetration enhancer and for its decongestant and anti-
tussive effects and in aromatherapy as a skin stimulant (Santos and
Rao, 2000). Our previous studies identiﬁed 1,8-cineole as a substance
with analgesic and anti-inﬂammatory, and hepatoprotective properties
and to attenuate the colonic damage in rats on acute trinitrobenzene
sulfonic acid-induced colitis, an animal model of inﬂammatory bowel
disease of humans (Santos and Rao, 2000; Santos et al., 2004). Few
other studies described 1,8-cineole as strong inhibitor of TNF-α and
IL-1β controlling airway mucus hypersecretion, suggesting its useful-
ness in asthma, sinusitis and chronic obstructive pulmonary disease
(Juergens et al., 2003, 2004), and as a compound possessing lipid-
lowering, antioxidant and anti-inﬂammatory properties in hypercho-
lesterolemic zebraﬁsh (Cho, 2012). These observations suggest that
1,8-cineole may have beneﬁcial effects in the management of acute
pancreatitis. Further, a recent study reported on the protective effects
of α-pinene yet another monoterpene present in plant essential oils,
in mice on cerulein-induced acute pancreatitis (Bae et al., 2012).
Therefore, this study was aimed to evaluate the protective effect of
1,8-cineole in a murine model of cerulein-induced pancreatitis that
presents the characteristics of human pancreatitis in its pathology.Materials and methods
Animals
Adult male Swiss mice weighing 25–30 g obtained from the central
animal house of this university were used. They were housed in poly-
propylene cages at 23 ± 2 °Cunder standard environmental conditions
(humidity 55%–60% and 12 h light–dark photoperiod) and had free
access to pellet diet (purina chow) and tap water. The animals were
fasted for 12 h before beginning the experiments and eight animals
were included in each group. Experimental protocols were approved
by the Institutional Committee on Care and Use of Animals for Experi-
mentation (No. 30/12) in accordancewith the guidelines of theNational
Institute of Health guide for the care and use of laboratory animals.Drugs
1,8-cineole and cerulein were purchased from Sigma-Aldrich
(St Louis, MO, USA) and thalidomide was purchased from Funed
(Belo Horizonte, MG, Brazil). 1,8-cineole was dissolved in normal saline
with 2% Tween 80 whereas all other drugs were dissolved in normal
saline (0.9% NaCl) immediately before use. All drugs were administered
at a volume of 10 mL/kg body weight.Cerulein-induced acute pancreatitis
Acute pancreatitis was induced by ﬁve intraperitoneal injections
of cerulein (50 μg/kg) at intervals of 1 h (Malleo et al., 2008). The
normal control mice were given intraperitoneal saline (0.9%, NaCl)
solution instead of cerulein injections. Six hours after the last injec-
tion of cerulein or saline, mice were anesthetized with pentobarbital
(40 mg/kg, i.p.), blood samples were drawn and the animals were
exsanguinated, and the pancreas was quickly removed and frozen at
−70 °C until use. 1,8-cineole (100, 200 and 400 mg/kg), thalidomide
(200 mg/kg) and vehicle (2% Tween 80 in 0.9% NaCl) were adminis-
tered orally 1 h prior to the ﬁrst administration of cerulein.Determination of pancreatic edema
The pancreatic weight/body weight ratio was evaluated as an esti-
mate of the degree of pancreatic edema (Szabolcs et al., 2006).
Determination of serum parameters
Blood samples were collected 6 h after the last cerulein administra-
tion and then centrifuged at 3000 ×g for 10 min at 4 °C. The serum am-
ylase and lipase levels were determinated with a colorimetric method
using a commercial kit for amylase (Labtest, MinasGerais, Brazil) and
lipase (Bioclin, Minas Gerais) and were expressed as U/L and U/dL,
respectively. Tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β),
IL-6, and IL-10 levels were estimated using the commercially available
immunoassay ELISA kits (Quantikine, R&D System, Minneapolis, MN,
USA), according to the manufacturer's instructions. The results were
expressed as pg/mL.
Pancreatic myeloperoxidase
The pancreatic myeloperoxidase (MPO) activity was determined
according to Bradley et al. (1982). Samples of pancreatic tissue were
homogenized in 50 mM of phosphate buffer (pH 6), containing 0.5%
hexadecyltrimethylammoniumbromide (HTAB). The samples were
freeze-thawed thrice with sonication between cycles and then the
samples were centrifugated at 40,000 ×g for 15 min. Aliquots of super-
natant were added to the reaction mixture containing 0.167 mg/mL
of o-dianisidine and 0.0005% H2O2 solution, which were prepared in
50 mM of phosphate buffer. The resulting change in absorbance at
460 nm was measured spectrophotometrically for 5 min. One unit of
MPO activity was deﬁned as that degrading 1 mmol of peroxide per
min at 25 °C. The activity was expressed as U/mg of tissue.
Pancreatic malondialdehyde
The concentration of pancreatic lipid peroxidation was determined
by estimating malondialdehyde (MDA) using the thiobarbituric acid
test (Agar et al., 1999). The pancreatic tissue was homogenized in KCl
0.15 M (pH 7.4). The homogenate was maintained in a water bath for
60 min at 37 °C. Perchloric acid (35%) was added to the homogenate
and centrifuged for 10 min at 40,000 ×g. The supernatant was mixed
with 1.2% thiobarbituric acid, and the mixture was heated at 98 °C for
30 min. After cooling to room temperature, the absorbance was mea-
sured at 532 nm. The standard curve was obtained using 1,1,3,3-
tetramethoxypropane. The results were expressed as nmol/g of tissue.
Pancreatic non-protein sulfhydryl groups (NP-SH)
The pancreatic NP-SH (reduced glutathione, GSH) were deter-
mined by Ellman's reaction using 5′5′-dithio-bis-2-nitrobenzoic acid
(DTNB) (Sedlak and Lindsay, 1968). Aliquots of 4 mL of the homoge-
nates in ice-cold ethylenediaminetetraacetic acid (EDTA; 0.02 mol/L;
pH 8.9) were mixed with 3.2 mL of distilled water and 0.8 mL of 50%
trichloroacetic acid (TCA). The tubes were centrifuged at 3000 ×g for
15 min. The supernatant (2 mL) was mixed with 4 mL Tris buffer
(0.4 mol/L; pH 8.9) and 0.1 mL of DTNB (0.01 mol/L). The absorbance
was measured within 5 min after addition of DTNB at 412 nm. The
absorbance values were extrapolated from a glutathione standard
curve. The results were expressed as μg/g of tissue.
Histological examinations
Samples of pancreatic tissue were ﬁxed in 10% buffered formalin
solution, embedded in parafﬁn using standard methods, cut into
5-mm sections, stained with hematoxylin–eosin, and then assessed
under light microscopy and examined blind by a morphologist for
Table 1
Effects of 1,8-cineole and thalidomide on serum amylase and lipase activities and on
the pancreatic weight/body weight ratio in mice.
Treatment Amylase (U/dL) Lipase (U/L) Pancreatic
weight/body weight
ratio (mg/g)
Normal 2985 ± 228.7 710.6 ± 108.8 4.45 ± 0.08
Vehicle 7298 ± 213.5a 1002.0 ± 159.1a 6.78 ± 0.31a
1,8-cineole 100 mg/kg 6276 ± 379.9a,b 504.7 ± 56.6b 6.34 ± 0.10a
1,8-cineole 200 mg/kg 6076 ± 274.2a,b 519.6 ± 95.3b 4.90 ± 0.18b
1,8-cineole 400 mg/kg 5768 ± 306.4a,b 577.2 ± 86.5b 5.60 ± 0.28b
Thalidomide 200 mg/kg 5973 ± 236.5a,b 599.0 ± 77.4b 5.56 ± 0.21b
Values are expressed as mean ± S.E.M. for 8 animals in each group.
a p b 0.05 compared with the normal group.
b p b 0.05 compared with the vehicle group (ANOVA followed by the Student
Newman Keul's test).
1197P.R. Lima et al. / Life Sciences 92 (2013) 1195–1201grading the histological alterations. Pancreatic edema, leukocyte inﬁl-
tration, acinar vacuolization, and necrosis were described with scores
ranging from 0 to 3 as described by Dembiński et al. (2008).
Immunohistochemistry for NF-кβ/p65
Immunohistochemical analysis of the expression of NF-κB was
performed using EnVision™ FLEX, High pH, kit (Code K8010, Dako,
Glostrup, Denmark) according to the manufacturer's instructions.
Sections of pancreas (4 μm) were transferred to silanized slides. Sec-
tions were deparafﬁnized and rehydrated through xylene and graded
alcohols. The slides were immersed into preheated (95–99 °C) Target
Retrieval Solution (EnVision™ FLEX, Dako, Glostrup, Denmark) in
water bath for 30 min. Endogenous peroxidase was blocked withNo
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Fig. 1. Effect of 1,8-cineole and thalidomide on serum TNF-α, IL-1β, IL-6, and IL-10 level
(200 mg/kg, p.o.) 1 h before cerulein administration. The vehicle group was treated with 2%
cerulein. Acute pancreatitis was induced by ﬁve injections of cerulein (50 μg/kg, i.p.) at inte
after the last cerulein administration. The data are expressed as the mean ± S.E.M. (n =
compared with the vehicle control (ANOVA followed by Student Newman Keul's test).Peroxidase-Blocking Reagent (EnVision™ FLEX, Dako, Glostrup,
Denmark) for 10 min and the nonspeciﬁc binding was blocked with
goat serum (1:200 in PBS) for 45 min. Slides were incubated with
primary rabbit anti-NFκB p50 subunit (Santa Cruz Biotechnology,
Santa Cruz, CA, USA) at 1:200 diluted in Antibody Diluent (EnVision™
FLEX, Dako, Glostrup, Denmark) for 60 min and then incubated with
secondary antibody polymer HRP (EnVision™ FLEX, Dako, Glostrup,
Denmark) for 30 min. Finally, the sections were stained with 3,3′-
diaminobenzidine (DAB) plus chromogen (EnVision™ FLEX, Dako,
Glostrup, Denmark) and counterstained with methyl green.
Statistical analysis
The nonparametric data are expressed as median (with low and
high ranges), and parametric data as mean ± standard error of the
mean (SEM). Statistical analysis was performed using one way analysis
of variance (ANOVA) followed byKruskal–Wallis or Student–Newman–
Keul as post-hoc tests. All data were analyzed using GraphPad Prism 5
(GraphPad Software Inc., La Jolla, CA, USA). Statistical differences were
considered to be signiﬁcant at p b 0.05.
Results
As shown in Table 1, the secretagogue cerulein (50 mg/kg/h, ×6, i.p.)
caused signiﬁcantly (p b 0.05) enhanced levels of serum amylase and
lipase when compared to values seen in vehicle-treated controls. Besides,
cerulein markedly increased (p b 0.05) the pancreatic wet weight/body
weight ratio, an index of pancreatic edema. While oral treatment with
1,8-cineole (100, 200 and 400 mg/kg) signiﬁcantly (p b 0.05) lowered
the cerulein-induced elevation of serum amylase and lipase at all doses,No
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s. Mice were pretreated with 1,8-cineole (100, 200, 400 mg/kg, p.o.) or thalidomide
Tween 80 in saline. The normal control mice were given saline (0.9% NaCl, i.p.) instead
rvals of 1 h. Serum TNF-α (A), IL-1β (B), IL-6 (C) and IL-10 (D) were determinate 6 h
8 animals for group). ap b 0.05, compared with the normal control and bp b 0.05,
1198 P.R. Lima et al. / Life Sciences 92 (2013) 1195–1201a signiﬁcant decrease in pancreatic edema was observed only at 200 and
400 mg/kg (Table 1). Lipase inhibition appeared more prominent than
to amylase with 1,8-cineole. Thalidomide (200 mg/kg, p.o.) manifested
similar reductions in serum amylase and lipase activities, as well as in
pancreatic edema.
Cerulein signiﬁcantly (p b 0.05) elevated the serum levels of TNF-α,
IL-1β, and IL-6, whereas the level of serum IL-10was decreased (Fig. 1).
Treatment with 1,8-cineole (100, 200 and 400 mg/kg, p.o.) and thalid-
omide (200 mg/kg, p.o.) effectively decreased the levels of TNF-α,
IL-1β, and IL-6 but the levels of IL-10 were increased (Fig. 1).
Cerulein caused a signiﬁcant (p b 0.05) increase in pancreatic MPO
activity and MDA levels and a decrease (p b 0.05) of pancreatic NP-SH
(Fig. 2). These changes were reversed by pretreatment with 1,8-cineole
(100, 200 and 400 mg/kg, p.o.) and thalidomide (200 mg/kg) in a sig-
niﬁcant manner.
Histological examination of the normal control showed normal
architecture and absence of edema, leukocyte inﬁltration, acinar
vacuolization, hemorrhage and necrosis (Fig. 3A and Table 2). In con-
trast, pancreatic sections from the cerulein group revealed extensive
tissue damage that was characterized by signiﬁcant disruption of
normal architecture, with massive edema, acinar cell vacuolization,
necrosis, hemorrhage and inﬂammatory cell inﬁltration, and thus
received signiﬁcantly higher scores (Fig. 3B and Table 2). Treatment
with 1,8-cineole (200 mg/kg, p.o.) and thalidomide (200 mg/kg, p.o.)0.0
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Fig. 2. Effect of 1,8-cineole and thalidomide on pancreaticMPO,MDA andNP-SH.Micewere
pretreatedwith 1,8-cineole (100, 200, 400 mg/kg, p.o.) or thalidomide (200 mg/kg, p.o.) 1 h
before cerulein administration. The vehicle group was treated with 2% Tween 80 in saline.
The normal control mice were given saline (0.9% NaCl, i.p.) instead of cerulein. Acute
pancreatitis was induced by ﬁve injections of cerulein (50 μg/kg, i.p.) at intervals of
1 h. Pancreatic myeloperoxidase (MPO) (A), malondialdehyde (MDA) (B) and non-protein
sulfhydryls (NP-SH) (D) were determinate 6 h after the last cerulein administration. The
data are expressed as the mean ± S.E.M. (n = 8 animals for group). ap b 0.05, compared
with the normal control and bp b 0.05, comparedwith the vehicle control (ANOVA followed
by Student Newman Keul's test).reduced the inﬂammation, and most strikingly the edema, and
protected the pancreas from histological damage induced by cerulein.
In addition, the total pathological scores were signiﬁcantly decreased
by 1,8-cineole and thalidomide treatment (Fig. 3C and d and Table 2).
Representative NF-κB immunostaining of the pancreas for different
treatments is shown in Fig. 4. In normal control, the pattern of NF-κB
staining was very mild (Fig. 4A). On the other hand, there was a high
intensity staining for NF-κB in the acinar cells, inﬂammatory cells and
blood vessels of the pancreas in the cerulein group (Fig. 4B), however,
in mice treated with 1,8-cineole (200 mg/kg, p.o.) or thalidomide
(200 mg/kg, p.o.), immunostaining intensity for NF-κB was much less
(Fig. 4C and D).
Discussion
Studies reveal that in acute pancreatitis (AP), pancreatic acinar
and stellate cells play an important role in leukocyte attraction via
secretion of chemokines, cytokines and expression of adhesion mole-
cules (Gukovskaya et al., 1997; Mews et al., 2002; Vonlaufen et al.,
2008). Neutrophils in particular exert their toxicity by releasing
myeloperoxidase (MPO), proteases such as elastase and reactive oxy-
gen species (ROS) such as H2O2. Cerulein is an analog of cholecystoki-
nin (CCK) and by its interaction with pancreatic acinar cells causes
the maximum pancreatic secretion of amylase and lipase (Jensen
et al., 1989), cytoplasmic vacuolization, death of acinar cells, edema
formation, and inﬁltration of inﬂammatory cells into the pancreas
(Gorelick et al., 1993), simulating the characteristics of human pan-
creatitis. The mechanism of action of cerulein is suggested to involve
production of large amounts of ROS, activation of oxidant-sensitive
transcription factor nuclear factor-kB (NF-kB) and induction of cyto-
kine expression in pancreas (Yu and Kim, 2012).
In our study, very high levels of MPO activity and MDA with a low
level of reduced glutathione were observed in cerulein-induced AP,
indicating that cerulein induces an oxidative stress, a ﬁnding con-
sistent with an earlier report (Jensen et al., 1989). The observed
decreases in the levels of MPO and MDA with an elevated glutathione
in 1,8-cineole-pretreated mice suggests that it protects the pancreatic
tissues from oxidative damage induced by cerulein, and this effect
possibly involves the inhibition of neutrophil inﬁltration and lipid
peroxidation.
In the diagnosis of AP, serum amylase and lipase remain important
tests with a high speciﬁcity. However, the major advantage of lipase
is an increased sensitivity in acute pancreatitis and in patients it
remains elevated longer than amylase (Yadav et al., 2002). Studies
even consider that serumpancreatic lipase is amore accurate biomarker
of acute pancreatitis than serum amylase (Smith et al., 2005). In this
study, 1,8-cineole although effectively reduced the cerulein-induced
increase in both lipase and amylase levels, cineole effect appeared
more pronounced on lipase, showing its relevance to human AP.
In addition to enhanced serum amylase and lipase activities, this
study noticed very high levels of proinﬂammatory cytokines, TNF-α,
IL-1β, and IL-6 and a low level of anti-inﬂammatory cytokine IL-10
in the serum of cerulein-induced AP. Activated acinar cells and
migrating cells release these pro-inﬂammatory cytokines in response
to the local damage in the pancreas (Kusske et al., 1996). One of the
early events in the development of AP is the release of these cytokines
from pancreatic tissue, and the level of cytokine release is related to
the degree of pancreatic inﬂammation (Mayer et al., 2000), and
their blockade attenuates the disease process. In our experiment,
these changes in cytokine levels were signiﬁcantly mitigated by
1,8-cineole pretreatment, suggesting that it may have an important
role in the inhibition of the pro-inﬂammatory response in AP. By
creating a balance between pro-inﬂammatory and anti-inﬂammatory
cytokines, 1,8-cineole might exercise a therapeutic beneﬁt for the con-
trol of acute pancreatitis. In this regard, previous studies provided
evidence for the role of 1,8-cineole in the control of airway mucus
A                          B
C                          D
Fig. 3. Representative photomicrographs of the pancreas. Mice were pretreated with 1,8-cineole (200 mg/kg, p.o.) or thalidomide (200 mg/kg, p.o.) 1 h before cerulein adminis-
tration. The vehicle group was treated with 2% Tween 80 in saline. The normal control mice were given saline (0.9% NaCl, i.p.) instead cerulein. Acute pancreatitis was induced
by ﬁve injections of cerulein (50 μg/kg, i.p.) at intervals of 1 h. The pancreas was examined histologically 6 h after the last cerulein administration. Normal control group showing
normal architecture (A), pancreas of animals treated with vehicle + cerulein showing disruption of pancreatic architecture with acinar cell vacuolization, acinar cell necrosis, and
inﬂammatory cell inﬁltration (B), 1,8-cineole (200 mg/kg) + cerulein (C), and thalidomide (200 mg/kg) + cerulein (D) showing reduction of acinar cell vacuolization, acinar cell
necrosis and inﬂammatory cell inﬁltration. Hematoxylin and eosin (×400).
1199P.R. Lima et al. / Life Sciences 92 (2013) 1195–1201hypersecretion by cytokine inhibition, suggesting that long-term treat-
mentwith 1,8-cineole can reduce exacerbations in asthma, sinusitis and
chronic obstructive pulmonary disease (Juergens et al., 2003, 2004).
NF-κB is a nuclear transcription factor responsible for regulating
the transcription of a wide variety of genes involved in immunity
and inﬂammation. This factor has been shown to play a critical role
in the development of acute pancreatitis (Rakonczay et al., 2008).
In addition, pro-inﬂammatory cytokines, particularly TNF-α, and oxi-
dative stress promote each other generating a vicious circle in acute
pancreatitis. Mice given injections of cerulein, to induce acute pancre-
atitis, had higher levels of NF-κB activity in pancreatic acinar cells
than control mice, consistent with earlier observations that correlate
the level of NF-κB activation with the severity of acute pancreatitis in
mice (Huang et al., 2013). Given the importance of TNF-α and NF-κB
in the pathogenesis of AP (Malleo et al., 2008; Pongratz et al., 2013),
blocking the action of these mediators by 1,8-cineole may be an
attractive treatment option to treat patients with AP.
Acute pancreatitis remains the most frequent complication of
endoscopic retrograde cholangiopancreatography (ERCP) for which an
ideal prophylactic drug is still not available. However, recently, a ran-
domized prospective controlled trial of rectal indomethacin revealedTable 2
Effects of 1,8-cineole and thalidomide treatment on morphological signs of pancreatic
damage.
Treatment Edema
(0–3)
Inﬂammatory
inﬁltration
(0–3)
Acinar
vacuolization
(0–3)
Necrosis
(0–3)
Normal 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0)
Vehicle 2.87 (2–3)a 2.75 (2–3)a 2.87 (2–3)a 2.62 (2–3)a
1,8-cineole 200 mg/kg 0.25 (0–1)b 0.25 (0–1)b 0.75 (0–1)b 0.37 (0–1)b
Thalidomide 200 mg/kg 0.50 (0–1)b 0.63 (0–1)b 0.87 (0–2)b 0.62 (0–1)b
Values are expressed as median scores ranges (min–max) for 8 animals in each group.
a p b 0.05 compared with the normal group.
b p b 0.05 compared with the vehicle group (ANOVA followed by the Kruskal–Wallis
test).signiﬁcant reduction in the incidence of ERCP pancreatitis (Cheon,
2013). It remains to be seen if rectal administration of 1,8-cineole
might also be a useful prophylactic measure to prevent ERCP associated
pancreatitis without collateral effects.
Although 1,8-cineole (200 mg/kg), reduced cerulein-induced
increase of amylase only to a less extent, histological evidence pro-
jects its marked protection against AP. The mild reduction of amylase
by 1,8-cineole compared to lipase might be the chemical characteris-
tic of this particular monoterpene. Another observation is that cineole
does not manifest dose-related responses in many of the observed
parameters. The responses were measured in relation to increasing
doses, expressed in terms of mg/kg body weight and not in relation
to blood level concentrations (μmol/L) of 1,8-cineole. Past studies
indicate that it has low bioavailability following the oral route, the rea-
sons being its rapid absorption, larger volume of distribution, storage in
fat tissues, and a rapid metabolism by liver cytochrome P450 enzymes
(CYP3A4). Another reason might be that the plasma concentrations
may not elevate with the increased doses due to simultaneously
enhanced metabolism of cineole by liver cytochrome P450 enzymes
(as it occurs in brushtail possum—Trichosurus vulpecula) (McLean
et al., 2007), resulting in increased blood levels of 2-hydroxy-cineole
(major metabolite of 1,8-cineole) but not the parent compound
1,8-cineole (Miyazawa et al., 2001). However, this notion requires a
bioavailability study analyzing the blood level concentrations of cineole
in relation to different doses given orally.
1,8-cineole (200 mg/kg) reduced the pancreatic weight (PW)/body
weight (BW) ratios as well as the TNF-α almost to the levels seen in
normal controls, which signify its histological evidence of protection
against cerulein-induced pancreatic damage. Since 1,8-cineole could
effectively modulate the NF-κB activation associated inﬂammatory
response, we assume that its anti-inﬂammatory activity might play a
major role in the amelioration of cerulein-induced acute pancreatitis.
Pain management in pancreatic disease remains a major clinical
concern. The transient receptor potential ankyrin 1 (TRPA1) channel
is well known to be affected by oxidative stress as shown in the
experimental models of itch or neuropathic pain (Liu and Ji, 2012;
A B
C D
Fig. 4. Effects of 1,8-cineole and thalidomide on NF-κB immunoreactivity in cerulein-induced acute pancreatitis. Mice were pretreated with 1,8-cineole (200 mg/kg, p.o.) or thalid-
omide (200 mg/kg, p.o.) 1 h before cerulein. The vehicle group was treated with 2% Tween 80 in saline. The normal control mice were given intraperitoneal saline (0,9% NaCl)
solution instead of cerulein. Acute pancreatitis was induced by ﬁve intraperitoneal injections of cerulein (50 μg/kg) at intervals of 1 h. NF-κB expression was measured by immu-
nohistochemistry 6 h after the last dose of cerulein. Normal control group showing basal immunostaining (A), pancreas of animals treated with vehicle showing disruption of
pancreatic architecture with acinar cell vacuolization, acinar cell necrosis, and inﬂammatory cell inﬁltration (B), 1,8-cineole (200 mg/kg, p.o.) (C), and thalidomide (200 mg/kg, p.o.)
(D) showing immunostaining comparable to the control group.
1200 P.R. Lima et al. / Life Sciences 92 (2013) 1195–1201Materazzi et al., 2012), and so is similarly in the pathogenesis of
pancreatitis and the associated inﬂammation and pain that could be
attenuated by TRPA1-channel antagonists (Schwartz et al., 2011).
Since 1,8-cineole has recently been reported to function as a TRPA1
inhibitor (Takaishi et al., 2012), it may be considered as an ideal
molecule for drug development, to prevent or treat patients with
acute pancreatitis.
Conclusion
In conclusion, this experimental study reveals that 1,8-cineole
by preventing the oxidative stress, inﬂammation, and acinar cell
injury attenuates the development of cerulein-induced acute pancre-
atitis in mice. 1,8-cineole may be in particular useful as prophy-
laxis against therapeutic drugs-induced and endoscopic retrograde
cholangiopancreatography (ERCP)-associated pancreatitis. However,
further detailed experimental and clinical evaluation on this mono-
terpenoid is necessary in the development of new therapeutic strate-
gies for treatment of acute pancreatitis.
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